Blau Farmacêutica S.A. (BVMF:BLAU3)

Blau Farmacêutica Revenue

Blau Farmacêutica had revenue of 486.60M BRL in the quarter ending June 30, 2026, with 4.68% growth. This brings the company's total for the last twelve months to 1.79B, up 1.06% year-over-year. In the year 2025, Blau Farmacêutica had annual revenue of 1.70B, down -2.96%. That makes Blau Farmacêutica the 13,367th largest company in the world by revenue and 178th in Brazil.

• Revenue (ttm): 1.79B
• Revenue Growth: +1.06%
• P/S Ratio: 1.65
• Revenue / Employee: 940.07K
• Employees: 1,900
• Market Cap: 2.95B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Hospital 1.43B 84.2%
• Retail+Aesthetics+Plasma 268.99M 15.8%

By Geography

Chart

• Brazil 1.55B 91.3%
• Colombia 68.34M 4.0%
• Uruguay 49.88M 2.9%
• Chile 20.42M 1.2%
• Peru 7.73M 0.5%
• Ecuador 1.50M 0.1%

Fiscal year ended Dec 31, 2025 See the full Blau Farmacêutica breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.70B	-51.99M	-2.96%
Dec 31, 2024	1.75B	381.74M	27.81%
Dec 31, 2023	1.37B	-34.28M	-2.44%
Dec 31, 2022	1.41B	40.50M	2.96%
Dec 31, 2021	1.37B	184.60M	15.62%

Data Source: S&P Global Market Intelligence Last updated: Aug 11, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 18, 2026

Data Sources Report a data error